Clareo Health | Perioperative Assessment of Right Ventricular Function and Venous Return in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery (Gyn Right) - Pilot Study
Perioperative Assessment of Right Ventricular Function and Venous Return in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery (Gyn Right) - Pilot Study
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Charite University, Berlin, Germany
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Offered patient information and written informed consent
Female patients aged greater than or equal to 18 years for cytoreductive surgery of a primary epithelial ovarian tumour
1. Patient Group 1: Female patients with \> 500 ml ascites in the preoperative sonographic examination
2. Patient group 2: Female patients aged \> 70 years and at least one of the following secondary diagnoses:
* Status Post stent placement due to coronary heart disease respectively Status Post-myocardial infarction
* existing arterial Hypertension for more than 5 years
* chronic heart failure (New York Heart Association (NYHA) class II-III)
* peripheral arterial disease
You may not be if
Patients aged less than 18 years
Persons without the capacity to consent
Inability of German language use
Lacking willingness to save and hand out data within the study
Accommodation in an institution due to an official or judicial order
(Unclear) history of alcohol or substances disabuse
Coworker of the Charité
Advanced disease of the oesophagus or upper respiratory tract at the beginning of hospitalization
Operation in the area of the oesophagus or nasopharynx within the last two months before participation in the study
Neurological or psychiatric disease at the beginning of hospitalization
CHF (congestive heart failure) according to (New York Heart Association) classification - NYHA class IV at the beginning of hospitalization
American Society of Anesthesiologists (ASA) classification greater than IV
Renal insufficiency (dependency of haemodialysis) at the beginning of hospitalization
Pulmonary oedema in thorax x-ray at the beginning of hospitalization
History of intracranial hemorrhage within one year before participation in the study
Conditions following venous thrombosis within the last three years before study inclusion
Known allergies or hypersensitivity on colloidal, starch or gelatine infusion solutions
Diabetes mellitus with signs of severe neuropathy
Known atrial fibrillation
Participation in an interventional clinical trial during the study period; exception: assignment to adjuvant therapy study during this study is allowed.
